nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Central nervous system drug development: An integrative biomarker approach toward individualized medicine
|
Gomez-Mancilla, B. |
|
2005 |
2 |
4 |
p. 683-695 |
artikel |
2 |
Central Nervous System Drug Development: An Integrative Biomarker Approach toward Individualized Medicine
|
Gomez-Mancilla, B. |
|
2005 |
2 |
4 |
p. 683-695 13 p. |
artikel |
3 |
Challenges in the development of novel treatment strategies for neuropathic pain
|
Ossipov, Michael H. |
|
2005 |
2 |
4 |
p. 650-661 |
artikel |
4 |
Challenges in the Development of Novel Treatment Strategies for Neuropathic Pain
|
Ossipov, Michael H. |
|
2005 |
2 |
4 |
p. 650-661 12 p. |
artikel |
5 |
Current concepts in therapeutic strategies targeting cognitive decline and disease modification in Alzheimer’s disease
|
Jacobsen, J. Steven |
|
2005 |
2 |
4 |
p. 612-626 |
artikel |
6 |
Current Concepts in Therapeutic Strategies Targeting Cognitive Decline and Disease Modification in Alzheimer's Disease
|
Jacobsen, J. Steven |
|
2005 |
2 |
4 |
p. 612-626 15 p. |
artikel |
7 |
Developing therapeutics for schizophrenia and other psychotic disorders
|
Marek, Gerard |
|
2005 |
2 |
4 |
p. 579-589 |
artikel |
8 |
Developing Therapeutics for Schizophrenia and Other Psychotic Disorders
|
Marek, Gerard |
|
2005 |
2 |
4 |
p. 579-589 11 p. |
artikel |
9 |
Developing therapeutics for the treatment of multiple sclerosis
|
Virley, David J. |
|
2005 |
2 |
4 |
p. 638-649 |
artikel |
10 |
Developing Therapeutics for the Treatment of Multiple Sclerosis
|
Virley, David J. |
|
2005 |
2 |
4 |
p. 638-649 12 p. |
artikel |
11 |
Drug discovery for disorders of the central nervous system
|
Pangalos, Menelas N. |
|
2005 |
2 |
4 |
p. 539-540 |
artikel |
12 |
Drug Discovery for Disorders of the Central Nervous System
|
Pangalos, Menelas N. |
|
2005 |
2 |
4 |
p. 539-540 2 p. |
artikel |
13 |
Drug metabolism and pharmacokinetics, the blood-brain barrier, and central nervous system drug discovery
|
Alavijeh, Mohammad S. |
|
2005 |
2 |
4 |
p. 554-571 |
artikel |
14 |
Drug Metabolism and Pharmacokinetics, the Blood-Brain Barrier, and Central Nervous System Drug Discovery
|
Alavijeh, Mohammad S. |
|
2005 |
2 |
4 |
p. 554-571 18 p. |
artikel |
15 |
Innovative approaches for the development of antidepressant drugs: Current and future strategies
|
Schechter, Lee E. |
|
2005 |
2 |
4 |
p. 590-611 |
artikel |
16 |
Innovative Approaches for the Development of Antidepressant Drugs: Current and Future Strategies
|
Schechter, Lee E. |
|
2005 |
2 |
4 |
p. 590-611 22 p. |
artikel |
17 |
Medicinal chemical properties of successful central nervous system drugs
|
Pajouhesh, Hassan |
|
2005 |
2 |
4 |
p. 541-553 |
artikel |
18 |
Medicinal Chemical Properties of Successful Central Nervous System Drugs
|
Pajouhesh, Hassan |
|
2005 |
2 |
4 |
p. 541-553 13 p. |
artikel |
19 |
New prospects and strategies for drug target discovery in neurodegenerative disorders
|
Hilbush, Brian S. |
|
2005 |
2 |
4 |
p. 627-637 |
artikel |
20 |
New Prospects and Strategies for Drug Target Discovery in Neurodegenerative Disorders
|
Hilbush, Brian S. |
|
2005 |
2 |
4 |
p. 627-637 11 p. |
artikel |
21 |
Targeting chronic and neuropathic pain: The N-type calcium channel comes of age
|
Snutch, Terrance P. |
|
2005 |
2 |
4 |
p. 662-670 |
artikel |
22 |
Targeting Chronic and Neuropathic Pain: The N-type Calcium Channel Comes of Age
|
Snutch, Terrance P. |
|
2005 |
2 |
4 |
p. 662-670 9 p. |
artikel |
23 |
The quest for market exclusivity in biotechnology: Navigating the patent minefield
|
Gersten, Judge David M. |
|
2005 |
2 |
4 |
p. 572-578 |
artikel |
24 |
The Quest for Market Exclusivity in Biotechnology: Navigating the Patent Minefield
|
Gersten, Judge David M. |
|
2005 |
2 |
4 |
p. 572-578 7 p. |
artikel |
25 |
Translational research in central nervous system drug discovery
|
Hurko, Orest |
|
2005 |
2 |
4 |
p. 671-682 |
artikel |
26 |
Translational Research in Central Nervous System Drug Discovery
|
Hurko, Orest |
|
2005 |
2 |
4 |
p. 671-682 12 p. |
artikel |